Butalid, Resciel C.

HRN: 27-65-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/21/2025
10/27/2025
IV
600 Mg
Q8hr
SSI
Waiting Final Action 
10/22/2025
MUPIROCIN 2%, 15G (TUBE)
10/22/2025
10/28/2025
TOPICAL
1ml
TID
SSI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: